A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis

Publisher： Karger

E-ISSN： 1421-9832|217|4|321-328

ISSN： 1018-8665

Source： Dermatology, Vol.217, Iss.4, 2008-09, pp. : 321-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcipotriol plus Betamethasone Dipropionate Scalp Formulation Is Effective and Well Tolerated in the Treatment of Scalp Psoriasis: A Phase II Study

By  

Dermatology, Vol. 217, Iss. 2, 2008-05 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Calcipotriol Solution for the Treatment of Scalp Psoriasis: Evaluation of Efficacy, Safety and Acceptance in 3,396 Patients

By  

Dermatology, Vol. 203, Iss. 2, 2001-09 ,pp. : 153-156

Karger

Access to resources Recommend Favorite

Treatment of Psoriasis with a New Combination of Calcipotriol and Betamethasone Dipropionate: A Flow Cytometric Study

By  

Dermatology, Vol. 203, Iss. 2, 2001-09 ,pp. : 148-152

Karger

Access to resources Recommend Favorite

Treatment of Nail Psoriasis with a Two-Compound Formulation of Calcipotriol plus Betamethasone Dipropionate Ointment

By  

Dermatology, Vol. 218, Iss. 4, 2009-02 ,pp. : 338-341

Karger

Access to resources Recommend Favorite